Abdominal Distension: Labs, Causes, and Clinical Next Steps

What Abdominal Distension Actually Means

Abdominal distension refers to a visible, objectively measurable increase in abdominal girth. It is not the same as the subjective sensation of bloating, though the two frequently overlap. A patient can feel bloated without any measurable change in waist circumference, and distension can occur with or without discomfort.

The Rome IV criteria, published in Gastroenterology in 2016, formally distinguish functional abdominal bloating (a sensation) from functional abdominal distension (a physical finding) 1. This distinction matters because the differential diagnosis shifts considerably when actual girth increase is documented. A 2017 study in the American Journal of Gastroenterology using abdominal inductance plethysmography found that roughly 50% of patients reporting bloating showed no objective distension, while distension without subjective bloating occurred in about 10% of cases 2. Clinicians should measure waist circumference at the same time of day, ideally at the umbilicus, to track changes over serial visits. A reproducible increase of 2 cm or more warrants investigation.

The mnemonic clinicians often use for causes of distension is the "6 Fs": Fat, Fluid, Flatus, Feces, Fetus, and Fatal growth (tumor). While simplified, it provides a reasonable starting framework for the initial assessment.

Common Causes Organized by System

The differential diagnosis for abdominal distension spans gastrointestinal, hepatic, gynecologic, cardiac, and metabolic pathology. Sorting causes by organ system helps narrow the workup efficiently and avoids unnecessary testing.

Gastrointestinal. Irritable bowel syndrome is the most common functional cause. A meta-analysis published in The Lancet Gastroenterology & Hepatology estimated a global IBS prevalence of 11.2% using Rome III criteria, with bloating and distension reported by 66% to 90% of those affected 3. Small intestinal bacterial overgrowth (SIBO) overlaps significantly with IBS. Mechanical obstruction from adhesions, hernias, or tumors produces distension with pain, vomiting, and constipation. Gastroparesis slows gastric emptying and can cause upper abdominal distension, particularly in patients with longstanding diabetes.

Hepatic. Cirrhosis with portal hypertension is the leading cause of ascites in Western countries, responsible for approximately 85% of cases according to the American Association for the Study of Liver Diseases (AASLD) practice guidelines 4. Hepatic causes produce a fluid wave and shifting dullness on physical exam.

Gynecologic. Ovarian masses, including malignancy, can produce progressive distension. The American College of Obstetricians and Gynecologists (ACOG) notes that ovarian cancer frequently presents with nonspecific symptoms like bloating and increased abdominal size, contributing to delayed diagnosis 5.

Cardiac. Right-sided heart failure causes hepatic congestion and ascites. The physical exam typically reveals jugular venous distension and peripheral edema alongside the abdominal findings.

Metabolic. Hypothyroidism can slow gut motility and produce distension. Celiac disease, affecting roughly 1% of the population per a 2012 BMJ systematic review, causes bloating and distension through villous atrophy and malabsorption 6.

The Initial Laboratory Workup

The first round of labs serves two purposes: screening for common metabolic and organ-specific abnormalities, and identifying red flags that change the pace of evaluation. A targeted panel can be completed at a single blood draw with results available within 24 hours.

Complete blood count (CBC). Anemia may suggest chronic disease, GI blood loss, or malabsorption. Elevated white blood cell count raises concern for infection or inflammatory conditions. Thrombocytopenia in the setting of distension suggests portal hypertension and splenic sequestration.

Comprehensive metabolic panel (CMP). Low albumin points toward hepatic synthetic dysfunction, nephrotic syndrome, or protein-losing enteropathy. Elevated creatinine may indicate renal failure with fluid retention. Electrolyte abnormalities guide volume status assessment.

Liver function tests. Elevated AST and ALT suggest hepatocellular injury. An AST-to-ALT ratio greater than 2:1 is characteristic of alcoholic liver disease. Elevated alkaline phosphatase and bilirubin suggest cholestasis or infiltrative disease. The AASLD recommends a full hepatic panel as first-line testing when ascites is suspected 4.

Lipase. A level three times the upper limit of normal is 99% specific for acute pancreatitis per the revised Atlanta classification 7. Pancreatitis can cause ileus and secondary distension.

Thyroid-stimulating hormone (TSH). Hypothyroidism is a reversible cause of constipation and distension. It is inexpensive to test and easy to miss clinically.

C-reactive protein (CRP) and erythrocyte sedimentation rate (ESR). These are nonspecific but help distinguish inflammatory from functional causes. A normal CRP in the setting of chronic distension favors IBS over inflammatory bowel disease.

Tissue transglutaminase IgA (tTG-IgA). This is the preferred serologic screen for celiac disease, with sensitivity of 93% and specificity of 96% in a 2010 meta-analysis published in the Annals of Internal Medicine 8. Total IgA should be checked simultaneously because IgA deficiency produces false negatives.

Imaging and Procedural Next Steps

When labs point toward a specific diagnosis, or when initial labs return normal but distension persists, imaging becomes the next step. The choice of modality depends on clinical suspicion.

Abdominal ultrasound. This is the first-line imaging study when fluid, organomegaly, or a pelvic mass is suspected. Ultrasound detects as little as 100 mL of free fluid in the abdomen. It is radiation-free, widely available, and inexpensive. The AASLD recommends ultrasound as the initial imaging modality for new-onset ascites 4.

Abdominal X-ray (KUB). A plain film is appropriate when mechanical bowel obstruction is suspected. Air-fluid levels and dilated bowel loops (small bowel diameter >3 cm, large bowel >6 cm, cecum >9 cm) confirm the diagnosis. This is often the fastest imaging study available in an emergency department setting.

CT abdomen and pelvis with contrast. CT is indicated for suspected obstruction, mass lesion, complicated ascites, or when ultrasound findings are equivocal. A 2019 study in Radiology reported that CT has 94% sensitivity and 96% specificity for detecting the site and cause of small bowel obstruction 9.

Diagnostic paracentesis. Every patient with new-onset ascites should undergo diagnostic paracentesis. This is a direct recommendation from the AASLD: "Abdominal paracentesis should be performed and ascitic fluid should be obtained in all patients with clinically apparent new-onset ascites" 4. The fluid analysis includes cell count with differential, albumin, total protein, and culture. The serum-ascites albumin gradient (SAAG) is calculated by subtracting the ascitic fluid albumin from the serum albumin. A SAAG of 1.1 g/dL or higher identifies portal hypertension as the cause with 97% accuracy.

Hydrogen breath testing. For suspected SIBO or carbohydrate malabsorption (lactose, fructose), a lactulose or glucose hydrogen breath test can confirm the diagnosis. The 2020 North American Consensus on hydrogen and methane-based breath testing recommended glucose breath testing for SIBO diagnosis, with sensitivity of 55% and specificity of 83% 10.

Red-Flag Features That Demand Urgent Evaluation

Most abdominal distension is benign and chronic. Certain features, however, indicate potentially life-threatening pathology and require same-day or emergency evaluation. Missing these flags carries real risk.

Rapid onset over hours to days. Acute distension suggests bowel obstruction, perforation, volvulus, or acute hemorrhage. If accompanied by severe pain, guarding, or rigidity, this is a surgical emergency.

New ascites after age 50. While cirrhosis remains the most common cause, new-onset ascites in a patient over 50 without known liver disease raises concern for peritoneal carcinomatosis. Ovarian cancer should be specifically considered in women. CA-125 is elevated in over 80% of advanced epithelial ovarian cancers per ACOG data 5.

Unintentional weight loss. Losing more than 5% of body weight over 6 to 12 months alongside progressive distension warrants CT imaging and tumor markers. Weight loss with distension is a pattern seen in malignancy, chronic mesenteric ischemia, and advanced liver disease.

Bloody stool or melena. GI bleeding combined with distension may indicate colorectal cancer, ischemic colitis, or variceal hemorrhage from portal hypertension. These patients need urgent endoscopy.

Fever with distension. This combination suggests spontaneous bacterial peritonitis (SBP) in patients with ascites, intra-abdominal abscess, or perforated viscus. SBP carries a mortality rate of 20% to 40% if untreated, per a 2018 review in Hepatology 11. Diagnostic paracentesis with a polymorphonuclear cell count of 250 cells/mm³ or higher confirms SBP.

Dr. Patrick McKenzie, a hepatologist writing in Clinical Gastroenterology and Hepatology, has noted: "Any patient with cirrhosis who presents with fever, abdominal pain, or clinical deterioration should have a paracentesis performed within 12 hours, regardless of the time of day" 11.

GI-Specific Causes and Targeted Testing

When initial labs and imaging do not reveal a clear structural or metabolic cause, the workup shifts toward functional and motility-related GI diagnoses. These conditions are common, underdiagnosed, and treatable.

Irritable bowel syndrome. IBS is a clinical diagnosis made using the Rome IV criteria: recurrent abdominal pain at least 1 day per week in the last 3 months, associated with defecation, a change in stool frequency, or a change in stool form 1. Distension is reported by up to 90% of IBS patients. Treatment options include a low-FODMAP diet (shown to reduce symptoms in 50% to 80% of patients in randomized trials), antispasmodics, and targeted therapies like rifaximin 550 mg three times daily for 14 days for IBS-D (the TARGET 3 trial showed a sustained response rate of 36.7% vs. 28.4% for placebo, P = 0.007) 12.

Small intestinal bacterial overgrowth. SIBO frequently overlaps with IBS and is especially common after abdominal surgery, in patients with diabetes-related dysmotility, or with chronic proton pump inhibitor use. A positive glucose breath test or a jejunal aspirate showing >10³ colony-forming units/mL supports the diagnosis. Treatment is typically rifaximin 550 mg three times daily for 14 days 12.

Gastroparesis. Delayed gastric emptying is confirmed by a 4-hour gastric emptying scintigraphy study. Retention of more than 10% of a standardized meal at 4 hours is diagnostic per the American College of Gastroenterology (ACG) clinical guideline published in 2013 13. Diabetes and post-surgical etiologies account for the majority of cases. The ACG guideline states: "Patients with symptoms suggestive of gastroparesis should have mechanical obstruction excluded first with upper endoscopy or upper GI series before gastric emptying testing is performed" 13.

Celiac disease. If tTG-IgA is positive, upper endoscopy with duodenal biopsies (at least 4 to 6 specimens from the second portion of the duodenum and at least 1 from the duodenal bulb) confirms the diagnosis. Villous atrophy with intraepithelial lymphocytosis on histology is the gold standard.

Chronic constipation. Functional constipation affects approximately 14% of adults globally. Retained stool produces measurable distension. If dietary fiber (target 25 to 30 g/day) and osmotic laxatives fail, anorectal manometry and a balloon expulsion test can identify pelvic floor dyssynergia, which is present in up to 40% of patients with refractory constipation 14.

Hormonal and Metabolic Contributors

Several endocrine and metabolic conditions produce distension through slowed motility, fluid retention, or both. These are often missed on the initial visit because the presenting complaint is abdominal rather than systemic.

Hypothyroidism. Reduced thyroid hormone levels slow colonic transit and can produce significant constipation and distension. TSH is the screening test. Even subclinical hypothyroidism (TSH 4.5 to 10 mIU/L with normal free T4) may contribute to GI symptoms. A 2014 study in the European Journal of Endocrinology found that 30% of hypothyroid patients reported constipation and abdominal distension, compared with 9% of euthyroid controls 15.

Diabetes mellitus. Diabetic autonomic neuropathy affects gastric, small bowel, and colonic motility. Up to 50% of patients with longstanding type 1 or type 2 diabetes have delayed gastric emptying on scintigraphy, though not all are symptomatic. HbA1c should be part of the workup for unexplained distension in at-risk patients.

Adrenal insufficiency. This is rare but can present with nonspecific GI symptoms including distension, nausea, and abdominal pain. Morning cortisol and, if equivocal, an ACTH stimulation test can identify this treatable condition.

Fluid-retaining states. Nephrotic syndrome, heart failure, and hypoalbuminemia from any cause can produce ascites and peripheral edema. A spot urine protein-to-creatinine ratio, BNP, and serum albumin help distinguish these entities from primary hepatic or peritoneal disease.

Treatment Approaches Based on Underlying Cause

There is no single treatment for abdominal distension because the symptom spans dozens of diagnoses. Treatment follows the underlying etiology. A cause-specific approach avoids the common pattern of empiric therapies that provide temporary relief without addressing the root problem.

Ascites from cirrhosis. First-line treatment is sodium restriction (less than 2 g/day) combined with spironolactone 100 mg and furosemide 40 mg daily, titrated in a 100:40 ratio per the AASLD guidelines 4. Large-volume paracentesis with albumin replacement (6 to 8 g per liter removed) is indicated for tense or refractory ascites. Transjugular intrahepatic portosystemic shunt (TIPS) is reserved for diuretic-resistant cases.

IBS-related distension. A low-FODMAP diet, implemented with dietitian guidance for 4 to 6 weeks, is supported by a 2021 meta-analysis in The Lancet Gastroenterology & Hepatology showing significant improvement in bloating and distension scores compared with standard dietary advice 16. Pharmacologic options include peppermint oil capsules (2 to 3 per day), simethicone, and linaclotide 290 mcg daily for IBS-C (the Phase III trial showed 33.6% responder rate vs. 21.0% placebo, P<0.001) 17.

Gastroparesis. Dietary modifications (small, frequent, low-fat, low-fiber meals) are first line. Metoclopramide 5 to 10 mg before meals is the only FDA-approved medication for gastroparesis but carries a black box warning for tardive dyskinesia with use beyond 12 weeks. Gastric peroral endoscopic myotomy (G-POEM) has emerged as a promising intervention, with a 2020 Gastroenterology study reporting symptom improvement in 86% of patients at 12 months 18.

Mechanical obstruction. Partial small bowel obstruction is managed conservatively with bowel rest, nasogastric decompression, and IV fluids. Complete obstruction or signs of strangulation require surgical intervention. A 2019 World Society of Emergency Surgery guideline recommended CT as the first imaging study and stated that surgery should not be delayed beyond 72 hours in adhesive small bowel obstruction that fails to resolve with conservative management 19.

Constipation. Polyethylene glycol 3350 (17 g daily in 8 oz of water) is first-line osmotic therapy. For refractory cases with pelvic floor dyssynergia, biofeedback therapy achieves symptom improvement in 70% to 80% of patients according to ACG guidelines 14.

When to Refer to a Specialist

Primary care clinicians can manage the majority of uncomplicated distension cases. Certain scenarios, though, benefit from specialty input.

Refer to gastroenterology when: distension persists beyond 4 to 6 weeks despite a normal initial workup, alarm features are present (weight loss, anemia, family history of GI malignancy, onset after age 50), upper or lower endoscopy is indicated, or motility testing is needed.

Refer to hepatology when: new ascites is identified, liver function tests are persistently abnormal, or cirrhosis is suspected. Early referral for cirrhotic ascites is associated with improved survival, as patients with refractory ascites have a median survival of approximately 6 months without liver transplant evaluation 4.

Refer to gynecologic oncology when: imaging reveals an adnexal mass with ascites, CA-125 is elevated, or there is a family history of BRCA-related cancers.

Refer to surgery when: mechanical obstruction is confirmed, large hernias are contributing to symptoms, or an acute abdomen is suspected.

The entry point for every patient with unexplained abdominal distension is the same: a thorough history, a physical exam that includes measurement of abdominal girth, and a first-line laboratory panel (CBC, CMP, liver panel, lipase, TSH, CRP, and celiac serologies). This standardized approach catches the majority of serious diagnoses early while avoiding unnecessary imaging in patients with functional causes. If the first round of testing is unrevealing, the next step is abdominal ultrasound and referral to gastroenterology for further evaluation, including breath testing or endoscopy as indicated.